Allende-Salazar Rubén F, Rada Gabriel
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile. Email:
Proyecto Epistemonikos, Santiago, Chile; Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Evidencia UC, Pontificia Universidad Católica de Chile, Santiago, Chile; GRADE working group; The Cochrane Collaboration.
Medwave. 2017 Jun 14;17(Suppl2):e6972. doi: 10.5867/medwave.2017.6972.
The use of cannabinoids has been proposed as an analgesic for different painful conditions, especially for chronic pain refractory to usual treatment. However, its real efficacy and safety remains controversial. We sought to determine whether cannabinoids are an effective treatment for chronic non-cancer pain. To answer this question, we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We identified 37 systematic reviews including 41 studies overall, of which 32 were randomized trials relevant for the question of interest. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis and generated a summary of findings table using the GRADE approach. We concluded it is not clear whether cannabinoids decrease pain in patients with chronic non-cancer pain because the certainty of available evidence is very low. On the other hand, they are associated with significant adverse effects.
大麻素已被提议作为治疗不同疼痛状况的镇痛药,尤其是对常规治疗难以治愈的慢性疼痛。然而,其实际疗效和安全性仍存在争议。我们试图确定大麻素是否是治疗慢性非癌性疼痛的有效方法。为回答这个问题,我们使用了Epistemonikos,这是健康领域最大的系统评价数据库,通过筛选包括MEDLINE、EMBASE、Cochrane等在内的多个信息来源来维护。我们识别出37项系统评价,总共包括41项研究,其中32项为与感兴趣问题相关的随机试验。我们从系统评价中提取数据,重新分析原始研究的数据,进行荟萃分析,并使用GRADE方法生成结果总结表。我们得出结论,由于现有证据的确定性非常低,尚不清楚大麻素是否能减轻慢性非癌性疼痛患者的疼痛。另一方面,它们与显著的不良反应相关。